Genome Editing of Pik3cd Impedes Abnormal Retinal Angiogenesis
Genome Editing of Pik3cd Impedes Abnormal Retinal Angiogenesis
复制标题
Pik3cd 的基因组编辑阻碍异常视网膜血管生成
DOI:
10.1089/hum.2022.079
复制
发表时间:
2022
影响因子:
4.2
通讯作者:
Hetian Lei
中科院分区:
文献类型:
--
作者:
Wenyi Wu;Gaoen Ma;Hui Qi;Lijun Dong;fang chen;Yun Wang;Xingxing Mao;Xiaoqing Guo;Jing Cui;Joanne Matsubara;Bart Vanhaesebroeck;Xiaohe Yan;Guoming Zhao;Shaochong Zhang;Hetian Lei
Abnormal angiogenesis is associated with myriad human diseases, including proliferative diabetic retinopathy (PDR). Signaling transduction through phosphoinositide 3-kinases (PI3Ks) plays a critical role in angiogenesis. Herein, we showed that p110δ, the catalytic subunit of PI3Kδ, was highly expressed in pathological retinal vascular endothelial cells (ECs) in a mouse model of oxygen-induced retinopathy (OIR) and in fibrovascular membranes from patients with PDR. To explore novel intervention with PI3Kδ expression, we developed a recombinant dual adeno-associated viral (rAAV) system for delivering CRISPR/Cas9 in whichStreptococcus pyogenes(Sp) Cas9 expression was driven by an endothelial specific promoter of the intercellular adhesion molecule 2 (pICAM2) to edit genomicPik3cd, the gene encoding p110δ. We then demonstrated that infection of cultured mouse vascular ECs with the dual rAAV1s of rAAV1-pICAM2-SpCas9 and rAAV1-SpGuide targeting genomicPik3cdresulted in 80% DNA insertion/deletion in the locus of genomicPik3cdand 70% depletion of p110δ expression. Furthermore, we showed that in the mouse model of OIR editing retinalPik3cdwith the dual rAAV1s resulted in not only a significant decrease in p110δ expression, and Akt activation, but also a dramatic reduction in pathological retinal angiogenesis. These findings reveal thatPik3cdediting is a novel approach to treating abnormal retinal angiogenesis.